298 related articles for article (PubMed ID: 11463558)
41. Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F
Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036
[TBL] [Abstract][Full Text] [Related]
42. Surgical management of non-small cell lung cancer with synchronous brain metastases.
Bonnette P; Puyo P; Gabriel C; Giudicelli R; Regnard JF; Riquet M; Brichon PY;
Chest; 2001 May; 119(5):1469-75. PubMed ID: 11348955
[TBL] [Abstract][Full Text] [Related]
43. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.
Yamamoto T; Kadoya N; Shirata Y; Koto M; Sato K; Matsushita H; Sugawara T; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Ito K; Katagiri Y; Takeda K; Jingu K
Radiat Oncol; 2015 Feb; 10():35. PubMed ID: 25886315
[TBL] [Abstract][Full Text] [Related]
44. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
45. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
46. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.
Vansteenkiste JF; De Leyn PR; Deneffe GJ; Stalpaert G; Nackaerts KL; Lerut TE; Demedts MG
Ann Thorac Surg; 1997 May; 63(5):1441-50. PubMed ID: 9146340
[TBL] [Abstract][Full Text] [Related]
47. Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?
Mordant P; Arame A; De Dominicis F; Pricopi C; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
Eur J Cardiothorac Surg; 2012 Mar; 41(3):617-22. PubMed ID: 22223700
[TBL] [Abstract][Full Text] [Related]
48. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
[TBL] [Abstract][Full Text] [Related]
50. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
51. Survival predictors in advanced non-small cell lung cancer.
Hespanhol V; Queiroga H; Magalhães A; Santos AR; Coelho M; Marques A
Lung Cancer; 1995 Dec; 13(3):253-67. PubMed ID: 8719065
[TBL] [Abstract][Full Text] [Related]
52. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
Liu T; Liu H; Li Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
[TBL] [Abstract][Full Text] [Related]
53. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
[TBL] [Abstract][Full Text] [Related]
54. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
55. Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival?
Modi A; Vohra HA; Weeden DF
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):467-73. PubMed ID: 19155223
[TBL] [Abstract][Full Text] [Related]
56. Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection.
Antuña AR; Vega MA; Sanchez CR; Fernandez VM
J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):101-107. PubMed ID: 28586934
[TBL] [Abstract][Full Text] [Related]
57. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
58. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
59. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
60. [Factors affecting the prognosis in patients with primary lung cancer and brain metastases].
Yurdakul AS; Halilçolar H; Oztürk C; Tatar D; Karakaya J
Tuberk Toraks; 2006; 54(3):235-42. PubMed ID: 17001540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]